Clinical Trial: DK210 (EGFR)

Trial Status: Open
Disease Types: Solid Tumors All, Lung, Colorectal, Basket Trials, Gynecologic, Head and Neck, Pancreatic
Return to All Clinical Trials
Trial ID DK210 (EGFR)
Sponsor ID DEKA Biosciences

Dose-finding Phase 1 Trial: Evaluating Safety and Biomarkers Using DK210 (EGFR) for Inoperable Locally Advanced and/or Metastatic EGFR+ Tumors With Progressive Disease Failing Systemic Therapy

Principal Investigator
Alexander I. Spira, MD, PhD, FACP
1 Location
Solid Tumors All
Lung
Colorectal
Basket Trials
Gynecologic
Head and Neck
Pancreatic
ClinicalTrials.gov NCT05704985

Locations

Fairfax Office

Learn More About This Trial
Other Relevant Trials
Trial ID TOS-358-001
Sponsor ID Totus

A Study to Evaluate the Safety and Tolerability of the Covalent Phosphoinositide-3-Kinase (PI3K)-alpha Inhibitor, TOS-358, in Adult Subjects with Select Solid Tumors

Principal Investigator
Alexander I. Spira, MD, PhD, FACP
1 Location
Solid Tumors All
VIRGINIA CANCER SPECIALISTS Learn More
ClinicalTrials.gov NCT05683418
Trial ID TAK-981-1502
Sponsor ID Takeda Oncology

Phase 1b/2 Study of TAK-981 Plus Pembrolizumab to Evaluate the Safety, Tolerability, and Antitumor Activity of the Combination in Patients With Select Advanced or Metastatic Solid Tumors

Principal Investigator
Alexander I. Spira, MD, PhD, FACP
1 Location
Lung
VIRGINIA CANCER SPECIALISTS Learn More
ClinicalTrials.gov NCT04381650
Return to All Clinical Trials
Return to Top